The rapid pace of innovation in the analytical tools space is playing a crucial role in driving the gene and cell therapy field towards an industrialized, commercially successful future. Technologies delivering enhanced accuracy, convenience, and time to result are reducing manufacturing and development costs and timelines while boosting quality. Droplet digital PCR (ddPCR) is a good example – a powerful and versatile tool with applications across the advanced therapies field, including the detection and quantification of DNA/RNA contaminants, viral vector copy number, and genome edits. In this hub, BioInsights presents a curated selection of content designed to answer your questions around the specific utility, considerations, and advantages in utilizing ddPCR from the early stages of product and process development through to clinical and commercial manufacture.